Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens. (2021)

First Author: Sawant N
Attributed to:  The Future Vaccine Manufacturing Research Hub (Vax-Hub) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.xphs.2020.11.039

PubMed Identifier: 33285182

Publication URI: http://europepmc.org/abstract/MED/33285182

Type: Journal Article/Review

Volume: 110

Parent Publication: Journal of pharmaceutical sciences

Issue: 3

ISSN: 0022-3549